Story thread · 3 reports / 3 sources
Freenome secures FDA nod for blood-based colorectal cancer test
medtechdive.com · 15d
How the coverage leans
Across 3 sources · syndicated copies counted once
Abbott will market Freenome’s SimpleScreen CRC test in the U.S., alongside its Cologuard stool test. SimpleScreen will compete with Guardant Health’s Shield blood test for colorectal cancer screening.
First report: FDA Approves Freenome's Blood Test for Colorectal Cancer Screening — medscape.com, 15d
The coverage
- FDA Approves New Blood Test for Colon Cancer Screening
medpagetoday.com · 15d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.